Vaccine trial for hand, foot, and mouth disease in young children
Part of Infections clinical trials.
This study tests a vaccine to protect against hand, foot, and mouth disease (HFMD) caused by four common viruses. It is for healthy children aged 6 to 71 months, and aims to see if the vaccine is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 71 months old.
- Your child must be generally healthy (no chronic severe illnesses like heart, liver, or kidney problems).
- Your child must not have had hand, foot, and mouth disease before.
- Your child must not have received certain vaccines or treatments in the past few weeks or months (study team will review).
- You must be willing to follow the study schedule and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This trial tests a new vaccine that protects against two common causes of hand, foot, and mouth disease, a viral illness that mostly affects young children. It may help prevent this uncomfortable and sometimes serious infection.
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
This study tests an experimental vaccine against hand, foot, and mouth disease in healthy children aged 6 to 71 months. The vaccine aims to protect against the EV71 virus, a common cause of this illness.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This trial tests whether breathing in a medication called pegylated interferon helps children with mild hand, foot, and mouth disease recover faster. It is for children ages 1 to 6 who have had symptoms like fever or rash for 3 days or less.
Hear when a new Hand, Foot, and Mouth Disease(HFMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.